Caribou Biosciences (CRBU) EBITDA Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | 65,154.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,154.00 |
| Dec 31, 2025 | 106,256.00 |
| Sep 30, 2025 | 40,798.00 |
| Jun 30, 2025 | -94,502.00 |
| Mar 31, 2025 | 875.00 |
| Dec 31, 2024 | -79,305.00 |
| Sep 30, 2024 | -161,728.00 |
| Jun 30, 2024 | -29,123.00 |
| Mar 31, 2024 | -93,376.00 |
| Dec 31, 2023 | -22,436.00 |
| Sep 30, 2023 | 77,888.00 |
| Jun 30, 2023 | -14,834.00 |
| Mar 31, 2023 | -2,597.00 |
| Dec 31, 2022 | 1,038.00 |
| Sep 30, 2022 | -29,311.00 |
| Jun 30, 2022 | 32,099.00 |
| Mar 31, 2022 | 7,737.00 |
| Dec 31, 2021 | 81,844.00 |
| Sep 30, 2021 | 15,951.00 |
| Jun 30, 2021 | -94,298.00 |
| Mar 31, 2021 | -21,659.00 |